Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Statistics

Total Valuation

ATNM has a market cap or net worth of $42.43 million. The enterprise value is -$7.64 million.

Market Cap	42.43M
Enterprise Value	-7.64M

Important Dates

The last earnings date was Friday, November 14, 2025, after market close.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ATNM has 31.20 million shares outstanding. The number of shares has increased by 7.11% in one year.

Current Share Class	31.20M
Shares Outstanding	31.20M
Shares Change (YoY)	+7.11%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.08%
Owned by Institutions (%)	19.79%
Float	30.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	495.67
Forward PS	n/a
PB Ratio	3.24
P/TBV Ratio	3.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.96, with a Debt / Equity ratio of 0.08.

Current Ratio	7.96
Quick Ratio	7.81
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -133.09% and return on invested capital (ROIC) is -85.10%.

Return on Equity (ROE)	-133.09%
Return on Assets (ROA)	-33.76%
Return on Invested Capital (ROIC)	-85.10%
Return on Capital Employed (ROCE)	-75.71%
Revenue Per Employee	$2,432
Profits Per Employee	-$935,108
Employee Count	37
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.41% in the last 52 weeks. The beta is -0.37, so ATNM's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	-1.41%
50-Day Moving Average	1.50
200-Day Moving Average	1.49
Relative Strength Index (RSI)	48.93
Average Volume (20 Days)	335,473

Short Selling Information

The latest short interest is 851,981, so 2.73% of the outstanding shares have been sold short.

Short Interest	851,981
Short Previous Month	822,396
Short % of Shares Out	2.73%
Short % of Float	2.76%
Short Ratio (days to cover)	3.23

Income Statement

In the last 12 months, ATNM had revenue of $90,000 and -$34.60 million in losses. Loss per share was -$1.12.

Revenue	90,000
Gross Profit	90,000
Operating Income	-37.34M
Pretax Income	-34.60M
Net Income	-34.60M
EBITDA	-37.12M
EBIT	-37.34M
Loss Per Share	-$1.12

Balance Sheet

The company has $53.39 million in cash and $1.14 million in debt, giving a net cash position of $52.25 million or $1.67 per share.

Cash & Cash Equivalents	53.39M
Total Debt	1.14M
Net Cash	52.25M
Net Cash Per Share	$1.67
Equity (Book Value)	13.78M
Book Value Per Share	0.44
Working Capital	47.53M

Cash Flow

Operating Cash Flow	-25.04M
Capital Expenditures	n/a
Free Cash Flow	-25.04M
FCF Per Share	-$0.80

Margins

Gross Margin	100.00%
Operating Margin	-41,486.67%
Pretax Margin	-38,443.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.11%
Shareholder Yield	-7.11%
Earnings Yield	-77.56%
FCF Yield	-56.14%

Analyst Forecast

The average price target for ATNM is $4.50, which is 230.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	230.88%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-31.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 11, 2020. It was a reverse split with a ratio of 1:30.

Last Split Date	Aug 11, 2020
Split Type	Reverse
Split Ratio	1:30

Scores

Altman Z-Score	n/a
Piotroski F-Score	2